Ligand Pharmaceuticals
NASDAQ: LGNDLa Jolla, US · Delaware corporation · 2 known investors
Founders & leadership
BB
MW
MATTHEW W. FOEHRExecutive
JL
JOHN L. HIGGINSExecutive
MK
MATTHEW KORENBERGExecutive
CS
CHARLES S. BERKMANExecutive
Board
DM
DAVID M. KNOTTBoard director
JA
JASON ARYEHBoard director
SS
STEPHEN SABBABoard director
JL
JOHN LAMATTINABoard director
TD
TODD DAVISBoard director
SP
SUNIL PATELBoard director
JK
JOHN KOZARICHBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$85.4M disclosed across 1 round · 2016
▶$85.4MraisedJan 2016 · 22 investors · PharmaceuticalsRule 506(c)
▶$85.4MraisedJan 2016 · 22 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- MATTHEW W. FOEHRDirector
- JOHN L. HIGGINSExecutive Officer, Director
- JOHN LAMATTINADirector
- TODD DAVISDirector
- SUNIL PATELDirector
- JOHN KOZARICHDirector
- MATTHEW KORENBERGDirector
- DAVID M. KNOTTDirector
- JASON ARYEHDirector
- CHARLES S. BERKMANDirector
- STEPHEN SABBADirector
- MELANIE HERMANDirector
- Offering amount
- $85.4M
- Amount sold
- $85.4M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Ligand Pharmaceuticals (LGND) Stock Pulls Back As Royalty Profit Strength Meets Valuation Doubts - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- Who founded Ligand Pharmaceuticals?
- Ligand Pharmaceuticals was founded by Brook Byers.
- Who are Ligand Pharmaceuticals's investors?
- Ligand Pharmaceuticals's investors include Sofinnova Ventures, Venrock.
- How much funding has Ligand Pharmaceuticals raised?
- Ligand Pharmaceuticals has disclosed $85.4M raised across 1 round.
- Where is Ligand Pharmaceuticals headquartered?
- Ligand Pharmaceuticals is headquartered in La Jolla, US.